Discover How CBD is Revolutionizing Psychosis Prevention: New Study Reveals Promising Results! In a groundbreaking study, researchers have discovered exciting new evidence on the impact of Cannabidiol (CBD) in preventing psychosis. As a non-intoxicating component of cannabis, CBD shows anxiolytic Read more…
Under-regulated THC Products Raise Safety Concerns In recent years, the market for THC products has witnessed remarkable growth, particularly in light of the Agriculture Improvement Act of 2018, known as the Farm Bill. **Delta-8 THC**, a notable component of this Read more…
Understanding the Popularity of Unlicensed Medical Cannabis Providers in Thailand In Thailand, the use of medical cannabis from unlicensed providers continues to thrive, despite the availability of licensed clinics. A recent qualitative study investigates the reasons behind this phenomenon, shedding Read more…
This comprehensive study, available on PubMed Central, examines the potential of targeting endocannabinoid degradation enzyme inhibitors for the development of new antipsychotic medications. Schizophrenia and other psychotic disorders often lack effective treatments with minimal side effects, driving the need for Read more…
Recent research published under the title “Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients” has revealed promising results regarding the use of medical cannabis among those undergoing palliative care for cancer. The study, accessible through the Read more…
Schizophrenia and related psychotic disorders pose significant challenges in contemporary psychiatry, necessitating the exploration of novel therapeutic approaches. Recent research has turned towards the endocannabinoid system and its role in psychiatric disorders. Notably, endocannabinoid degradation enzyme inhibitors have emerged as Read more…
Recent research has highlighted the significant therapeutic potential of Cannabidiol (CBD) in managing social stress and enhancing emotional support among patients. This summary delves into the comprehensive study published in the National Center for Biotechnology Information (NCBI), which investigates how Read more…
Parkinsonβs disease (PD) is a progressive neurodegenerative disorder marked by the loss of dopamine-producing neurons in the brain, leading to motor and non-motor symptoms. Recent research has explored the therapeutic potential of cannabidiol (CBD), a non-psychoactive compound found in cannabis, Read more…
Arthritis, characterized by debilitating inflammation and chronic pain, significantly impacts the quality of life for millions globally. Recent research has highlighted a promising therapeutic approach using transdermal cannabidiol (CBD). In a study published by NCBI, the efficacy of transdermal CBD Read more…
Cannabidiol (CBD), a non-psychoactive compound found in cannabis, has garnered significant attention due to its potential therapeutic effects across a variety of conditions. One of the critical pathways through which CBD exerts these effects is by enhancing anandamide signaling within Read more…
